SC 13D Filing

Company

INTERPACE BIOSCIENCES, INC.

Filed

March 1, 2021

Accession Number

0001171520-21-000113

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →